Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2016

Aug 15, 2016

32337_dirs_2016-08-15_d4150032-5bc1-4da2-a53a-81387f522c37.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2016-08-11

Reporting Person: Fleming Ibelis (SVP/Managing Dir North America)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-08-11 Common Stock M 10000 $6.82 Acquired 14143 Direct
2016-08-11 Common Stock D 1050 $65.00 Disposed 13093 Direct
2016-08-11 Common Stock F 3364 $65.00 Disposed 9729 Direct
2016-08-11 Common Stock S 4143 $64.81 Disposed 5586 Direct
2016-08-15 Common Stock S 5586 $64.89 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-08-11 Stock Appreciation Rights $6.82 M 10000 Disposed 2019-02-27 Common Stock (10000) Direct

Footnotes

F1: The total number of shares has been adjusted to include 785 shares inadvertently omitted from prior reports.

F2: The reporting person received 5,586 shares of common stock upon the net exercise of 10,000 stock appreciation rights ("SARs"). The reporting person forfeited 1,050 shares of common stock underlying the SARs in payment of the exercise price and 3,364 shares of common stock underlying the SARs to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on August 11, 2016 of $65.00.

F3: This transaction was executed in multiple trades at prices ranging from $64.73 to $64.95. The price reported reflects the weighted average sale price of $64.81. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission (the "Staff"), the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: This transaction was executed in multiple trades at prices ranging from $64.82 to $65.01. The price reported reflects the weighted average sale price of $64.89. The reporting person hereby undertakes to provide upon request by the Staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.